Your browser doesn't support javascript.
loading
Resialylation of sialic acid deficit vascular endothelium, circulating cells and macromolecules may counteract the development of atherosclerosis: a hypothesis.
Lindberg, Gunnar.
Afiliação
  • Lindberg G; The NEPI Foundation (The Swedish Network for Pharmacoepidemiology), Clinical Research Centre, Malmö University Hospital, Malmö, Sweden. gunnar.lindberg@nepi.net <gunnar.lindberg@nepi.net>
Atherosclerosis ; 192(2): 243-5, 2007 Jun.
Article em En | MEDLINE | ID: mdl-17420020
ABSTRACT
Deficit sialylation of vascular endothelium, circulating cells and macromolecules has been associated with the development of atherosclerosis. On the other hand, an elevated serum level of sialic acid is a long-lasting marker of atherosclerosis and complications from atherosclerosis. One may speculate that the inverse associations with atherosclerosis risk are due to some common underlying cause. One mission for the elevated serum sialic acid level might be to act as a substrate for resialylation of sialic acid deficit structures and thereby counteract the atherosclerotic process.
Assuntos
Buscar no Google
Base de dados: MEDLINE Assunto principal: Endotélio Vascular / Ácido N-Acetilneuramínico / Aterosclerose Tipo de estudo: Etiology_studies Limite: Humans Idioma: En Revista: Atherosclerosis Ano de publicação: 2007 Tipo de documento: Article
Buscar no Google
Base de dados: MEDLINE Assunto principal: Endotélio Vascular / Ácido N-Acetilneuramínico / Aterosclerose Tipo de estudo: Etiology_studies Limite: Humans Idioma: En Revista: Atherosclerosis Ano de publicação: 2007 Tipo de documento: Article